Health ❯ Healthcare ❯ Clinical Research

Drug Approval

FDA Anvisa FDA Approval FDA Regulations NICE Guidelines Clinical Trials Post-Market Surveillance FDA Reports FDA and EMA FDA and EMA Regulations

7 ARTICLES

2mo ago

Japan Orders Warning for Tabneos After 20 Deaths Linked to Liver Dysfunction

Regulators told Kissei to add a package-insert warning to flag fatal liver risks during an investigation into whether the vasculitis drug caused the deaths.

9 ARTICLES

3mo ago

Lilly Launches First Amyloid-Targeting Alzheimer’s Drug in India at Rs 91,688 a Dose

3 ARTICLES

5mo ago

One in Three Infants Received Preventive RSV Antibody in First Season, Study Finds

3 ARTICLES

last yr.

FDA Approves Merck’s Enflonsia Monoclonal Antibody for Infant RSV Prevention

Drug Approval

Japan Orders Warning for Tabneos After 20 Deaths Linked to Liver Dysfunction

Lilly Launches First Amyloid-Targeting Alzheimer’s Drug in India at Rs 91,688 a Dose

Anvisa Approves Tzield, First Therapy to Delay Onset of Type 1 Diabetes

Anvisa Expands Wegovy and Ozempic Uses to Cardiovascular and Kidney Protection

IQWiG Says Leqembi Shows No Added Benefit for Early Alzheimer’s Patients

Intranasal Epinephrine Nears AIFA Sign-Off, Italian Launch Targeted for 2026

Leqembi Launches in Germany for Early Alzheimer’s Patients

One in Three Infants Received Preventive RSV Antibody in First Season, Study Finds

FDA Approves Merck’s Enflonsia Monoclonal Antibody for Infant RSV Prevention